WO2007054182A3 - Nanopartikel als kontrastmittel für die kernspintomographie - Google Patents

Nanopartikel als kontrastmittel für die kernspintomographie Download PDF

Info

Publication number
WO2007054182A3
WO2007054182A3 PCT/EP2006/009982 EP2006009982W WO2007054182A3 WO 2007054182 A3 WO2007054182 A3 WO 2007054182A3 EP 2006009982 W EP2006009982 W EP 2006009982W WO 2007054182 A3 WO2007054182 A3 WO 2007054182A3
Authority
WO
WIPO (PCT)
Prior art keywords
magnetic resonance
resonance imaging
contrasting agents
nanoparticles used
several
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2006/009982
Other languages
English (en)
French (fr)
Other versions
WO2007054182A2 (de
Inventor
Armin Kuebelbeck
Heike Schilke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to US12/093,187 priority Critical patent/US20080286370A1/en
Priority to JP2008539280A priority patent/JP2009514905A/ja
Priority to EP06806318A priority patent/EP1945192A2/de
Publication of WO2007054182A2 publication Critical patent/WO2007054182A2/de
Publication of WO2007054182A3 publication Critical patent/WO2007054182A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1878—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles the nanoparticle having a magnetically inert core and a (super)(para)magnetic coating
    • A61K49/1881—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles the nanoparticle having a magnetically inert core and a (super)(para)magnetic coating wherein the coating consists of chelates, i.e. chelating group complexing a (super)(para)magnetic ion, bound to the surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicinal Preparation (AREA)

Abstract

Gegenstand der Erfindung sind nanoskalige Partikel als Kontrastmittel für die Kernspintomographie bestehend aus einem Kern mit einer inerten Matrix, einem oder mehreren kovalent gebundenen organischen Komplexbildnern in welchem ein oder mehrere Metallionen mit ungepaarten Elektronen gebunden sind und ggf. einem oder mehreren, an der Oberfläche der Kerne kovalent gebundenen Biomolekülen sowie ein Verfahren zur Herstellung dieser Nanopartikel.
PCT/EP2006/009982 2005-11-10 2006-10-17 Nanopartikel als kontrastmittel für die kernspintomographie Ceased WO2007054182A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US12/093,187 US20080286370A1 (en) 2005-11-10 2006-10-17 Nanoscale Particles Used as Contrasting Agents in Magnetic Resonance Imaging
JP2008539280A JP2009514905A (ja) 2005-11-10 2006-10-17 磁気共鳴映像法用の造影剤としてのナノスケール粒子
EP06806318A EP1945192A2 (de) 2005-11-10 2006-10-17 Nanoskalige partikel als kontrastmittel für die kernspintomographie

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005053618A DE102005053618A1 (de) 2005-11-10 2005-11-10 Nanoskalige Partikel als Kontrastmittel für die Kernspintomographie
DE102005053618.2 2005-11-10

Publications (2)

Publication Number Publication Date
WO2007054182A2 WO2007054182A2 (de) 2007-05-18
WO2007054182A3 true WO2007054182A3 (de) 2007-07-05

Family

ID=37944817

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/009982 Ceased WO2007054182A2 (de) 2005-11-10 2006-10-17 Nanopartikel als kontrastmittel für die kernspintomographie

Country Status (7)

Country Link
US (1) US20080286370A1 (de)
EP (1) EP1945192A2 (de)
JP (1) JP2009514905A (de)
KR (1) KR20080066999A (de)
CN (1) CN101340900A (de)
DE (1) DE102005053618A1 (de)
WO (1) WO2007054182A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009045579A2 (en) * 2007-06-14 2009-04-09 The Regents Of The University Of California Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics
US8147802B2 (en) * 2007-09-28 2012-04-03 General Electric Company Chelator-functionalized nanoparticles
WO2009143720A1 (en) * 2008-05-27 2009-12-03 The Chinese University Of Hong Kong Nanoparticles, methods of making same and cell labelling using same
WO2010076946A1 (ko) * 2008-12-30 2010-07-08 경북대학교 산학협력단 나노입자체, 복합 나노입자체 및 이의 제조방법
EP2687234A4 (de) 2011-03-18 2014-09-24 Konica Minolta Inc Silica-nanopartikel zur diagnostischen bilderzeugung, herstellungsverfahren dafür und biosubstanzen-markierungsmittel
CN103007302B (zh) * 2012-12-12 2014-11-26 中国科学院宁波材料技术与工程研究所 Gd2O3-TiO2复合纳米粒子及其制备方法和应用
US10160884B2 (en) * 2015-03-23 2018-12-25 Versum Materials Us, Llc Metal compound chemically anchored colloidal particles and methods of production and use thereof
US20210379208A1 (en) * 2020-06-08 2021-12-09 Massachusetts Institute Of Technology Molecular sensors with modified ligands
CN114678179B (zh) * 2020-12-24 2025-11-14 中国科学院宁波材料技术与工程研究所 一种亲水磁性实心纳米球及其制备方法与应用
CN115869426B (zh) * 2022-12-28 2025-08-12 华润双鹤药业股份有限公司 一种钆特酸葡胺注射液及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216278A2 (de) * 1985-09-25 1987-04-01 MERCK PATENT GmbH Kugelförmige Kieselsäure-Partikel
WO1996009840A1 (en) * 1994-09-27 1996-04-04 Nycomed Imaging A/S Contrast agent
WO2000030688A2 (en) * 1998-11-26 2000-06-02 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
WO2004009134A1 (en) * 2002-07-22 2004-01-29 Bracco Imaging S.P.A. Procedures of cellular labelling with paramagnetic complexes for mri applications
WO2004083902A2 (en) * 2002-10-25 2004-09-30 Georgia Tech Research Corporation Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring
WO2005107818A2 (en) * 2004-04-30 2005-11-17 University Of Florida Nanoparticles and their use for multifunctional bioimaging
WO2007013877A2 (en) * 2004-09-02 2007-02-01 The Regents Of The University Of California Signal peptide-semiconductor nanocrystal conjugates

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216278A2 (de) * 1985-09-25 1987-04-01 MERCK PATENT GmbH Kugelförmige Kieselsäure-Partikel
WO1996009840A1 (en) * 1994-09-27 1996-04-04 Nycomed Imaging A/S Contrast agent
WO2000030688A2 (en) * 1998-11-26 2000-06-02 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
WO2004009134A1 (en) * 2002-07-22 2004-01-29 Bracco Imaging S.P.A. Procedures of cellular labelling with paramagnetic complexes for mri applications
WO2004083902A2 (en) * 2002-10-25 2004-09-30 Georgia Tech Research Corporation Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring
WO2005107818A2 (en) * 2004-04-30 2005-11-17 University Of Florida Nanoparticles and their use for multifunctional bioimaging
WO2007013877A2 (en) * 2004-09-02 2007-02-01 The Regents Of The University Of California Signal peptide-semiconductor nanocrystal conjugates

Also Published As

Publication number Publication date
KR20080066999A (ko) 2008-07-17
WO2007054182A2 (de) 2007-05-18
JP2009514905A (ja) 2009-04-09
DE102005053618A1 (de) 2007-05-16
US20080286370A1 (en) 2008-11-20
EP1945192A2 (de) 2008-07-23
CN101340900A (zh) 2009-01-07

Similar Documents

Publication Publication Date Title
Sun et al. Polymer mediated self-assembly of magnetic nanoparticles
Yulikov et al. Binding of single gold atoms on thin MgO (001) films
Nogués et al. Exchange bias in nanostructures
Goon et al. Controlled fabrication of polyethylenimine-functionalized magnetic nanoparticles for the sequestration and quantification of free Cu2+
GB0313259D0 (en) Magnetic nanoparticles
WO2007054182A3 (de) Nanopartikel als kontrastmittel für die kernspintomographie
WO2008073171A3 (en) Monodisperse single-walled carbon nanotube populations and related methods for providing same
EP3980797A1 (de) Vorrichtung und verfahren zur verwendung von diamant-nanokristallen mit nv-farbzentren in cmos-schaltkreisen
TW200626747A (en) Selective placement of carbon nanotubes on oxide surfaces
WO2006113192A3 (en) Functional nanoparticle filled carbon nanotubes and methods of their production
EP1199123A4 (de) Ultrafeine komposit/metall partikel
WO2009097319A3 (en) Water-soluble nanocrystals through dual-interaction ligands
WO2008030862A3 (en) Magnetic particles and methods of making and using the same
WO2012125693A3 (en) Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same
WO2008005055A3 (en) Nanoparticles containing titanium oxide
WO2012141205A3 (ja) L10型FeNi合金粒子及びその製造方法、磁性組成物並びに磁石
EP1651957A4 (de) Fluoreszierende magnetische nanopartikel und herstellungsverfahren
WO2006073439A3 (en) Surface enhanced spectroscpy-active composite nanop articles and their application in analysis and diagnosis
WO2006068653A3 (en) Nanoparticles with inorganic core and methods of using them
EP1988183A4 (de) R-t-b legierung, herstellungsverfahren dafür, feines pulver für einen permanenten r-t-b-seltenerdmagneten, und permanenter r-t-b-seltenerdmagnet
DE602008005286D1 (de) Schloss zur haltung eines zweirädrigen fahrzeugs im geparkten zustand
WO2009053596A3 (fr) Nouveau procede de preparation de nanoparticules recouvertes d'une couche stabilisatrice gem-bisphosphonate couplee a des ligands de biodistribution hydrophile
WO2007008249A3 (en) Method for making metallic nanostructures
WO2006125222A3 (en) Magnetically-responsive microparticles with improved response times
Nguyen et al. Adsorption kinetics and reversibility of linear plasmid DNA on silica surfaces: influence of alkaline earth and transition metal ions

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680041311.6

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006806318

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2008539280

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12093187

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2206/KOLNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 1020087013785

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2006806318

Country of ref document: EP